| pubmed-article:2068028 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2068028 | lifeskim:mentions | umls-concept:C0018802 | lld:lifeskim |
| pubmed-article:2068028 | lifeskim:mentions | umls-concept:C1565489 | lld:lifeskim |
| pubmed-article:2068028 | lifeskim:mentions | umls-concept:C0243161 | lld:lifeskim |
| pubmed-article:2068028 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
| pubmed-article:2068028 | lifeskim:mentions | umls-concept:C1524081 | lld:lifeskim |
| pubmed-article:2068028 | lifeskim:mentions | umls-concept:C0332282 | lld:lifeskim |
| pubmed-article:2068028 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
| pubmed-article:2068028 | lifeskim:mentions | umls-concept:C0521116 | lld:lifeskim |
| pubmed-article:2068028 | pubmed:issue | 786 | lld:pubmed |
| pubmed-article:2068028 | pubmed:dateCreated | 1991-8-15 | lld:pubmed |
| pubmed-article:2068028 | pubmed:abstractText | Angiotensin-1-converting enzyme inhibitors have an effective and established role in the treatment of patients with congestive heart failure. However, a small number of such patients will subsequently develop renal insufficiency. These patients may be identified prior to, or shortly after, commencement of therapy by recognized criteria. This report describes 4 patients with congestive heart failure who developed severe renal insufficiency secondary to either enalapril or captopril therapy in the absence of any currently recognized predisposing factors. One patient died. | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2068028 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2068028 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2068028 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2068028 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:2068028 | pubmed:issn | 0032-5473 | lld:pubmed |
| pubmed-article:2068028 | pubmed:author | pubmed-author:RussellGG | lld:pubmed |
| pubmed-article:2068028 | pubmed:author | pubmed-author:CarsonPP | lld:pubmed |
| pubmed-article:2068028 | pubmed:author | pubmed-author:OdumJJ | lld:pubmed |
| pubmed-article:2068028 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2068028 | pubmed:volume | 67 | lld:pubmed |
| pubmed-article:2068028 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2068028 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2068028 | pubmed:pagination | 354-7 | lld:pubmed |
| pubmed-article:2068028 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:2068028 | pubmed:meshHeading | pubmed-meshheading:2068028-... | lld:pubmed |
| pubmed-article:2068028 | pubmed:meshHeading | pubmed-meshheading:2068028-... | lld:pubmed |
| pubmed-article:2068028 | pubmed:meshHeading | pubmed-meshheading:2068028-... | lld:pubmed |
| pubmed-article:2068028 | pubmed:meshHeading | pubmed-meshheading:2068028-... | lld:pubmed |
| pubmed-article:2068028 | pubmed:meshHeading | pubmed-meshheading:2068028-... | lld:pubmed |
| pubmed-article:2068028 | pubmed:meshHeading | pubmed-meshheading:2068028-... | lld:pubmed |
| pubmed-article:2068028 | pubmed:meshHeading | pubmed-meshheading:2068028-... | lld:pubmed |
| pubmed-article:2068028 | pubmed:meshHeading | pubmed-meshheading:2068028-... | lld:pubmed |
| pubmed-article:2068028 | pubmed:meshHeading | pubmed-meshheading:2068028-... | lld:pubmed |
| pubmed-article:2068028 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:2068028 | pubmed:articleTitle | Congestive heart failure and converting enzyme inhibition: failure of current prognostic criteria for predicting subsequent renal insufficiency. | lld:pubmed |
| pubmed-article:2068028 | pubmed:affiliation | Department of Nephrology, North Staffordshire Royal Infirmary, Hartshill, Stoke on Trent, UK. | lld:pubmed |
| pubmed-article:2068028 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2068028 | pubmed:publicationType | Case Reports | lld:pubmed |
